A carbamazepine trial in chronic, treatment-refractory schizophrenia

J. Sramek, J. Herrera, J. Costa, C. Heh, T. Tran-Johnson, G. Simpson

Research output: Contribution to journalArticlepeer-review

Abstract

Carbamazepine was given to 12 chronic, treatment-refractory schizophrenic patients for 5 weeks. No overall change was found, but four patients significantly improved while eight worsened. Given the paucity of successful treatments for refractory schizophrenia, further study of carbamazepine appears warranted.

Original languageEnglish (US)
Pages (from-to)748-750
Number of pages3
JournalAmerican Journal of Psychiatry
Volume145
Issue number6
DOIs
StatePublished - 1988
Externally publishedYes

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'A carbamazepine trial in chronic, treatment-refractory schizophrenia'. Together they form a unique fingerprint.

Cite this